FOXP3 and immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome: Moreover, second-line investigations should consider the possible effect of FOXP3 mutations in Tregs, which result largely in dysregulation in IPEX patients, as previously illustrated.